Pilar Rivera‐Ortega
- Co-authors
- María Molina‐MolinaNazia ChaudhuriC.T. LeonardJohn BlaikleyConal HaytonStefan StanelSoraya L. VallésJavier Alcácer
- Topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers)Sarcoidosis and Beryllium Toxicity Research (6 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers)
- Partner nations
- United KingdomSpainUnited States
In The Last Decade
Pilar Rivera‐Ortega
24 papers receiving 267 citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 159
- Physiology 63
- Molecular Biology 41
- Neurology 33
- Surgery 23
Countries citing papers authored by Pilar Rivera‐Ortega
This map shows the geographic impact of Pilar Rivera‐Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Rivera‐Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Rivera‐Ortega more than expected).
Fields of papers citing papers by Pilar Rivera‐Ortega
This network shows the impact of papers produced by Pilar Rivera‐Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Rivera‐Ortega. The network helps show where Pilar Rivera‐Ortega may publish in the future.
Co-authorship network of co-authors of Pilar Rivera‐Ortega
This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Rivera‐Ortega. A scholar is included among the top collaborators of Pilar Rivera‐Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Rivera‐Ortega. Pilar Rivera‐Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 30 | |
| 3 | 2 | |
| 4 | 12 | |
| 5 | 6 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 17 | |
| 9 | 1 | |
| 10 | 28 | |
| 11 | 16 | |
| 12 | 2 | |
| 13 | 4 | |
| 14 | 49 | |
| 15 | 8 | |
| 16 | Glucocorticoid receptor antagonism overcomes resistance to BRAF inhibition in BRAFV600E-mutated metastatic melanoma. | 15 |
| 17 | 65 | |
| 18 | 1 | |
| 19 | 0 | |
| 20 | 1 |
About Pilar Rivera‐Ortega
Pilar Rivera‐Ortega is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Toxicology, having authored 26 papers that have together received 273 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (159 citations), Geriatrics and Gerontology (11 citations) and Physiology (63 citations). Pilar Rivera‐Ortega has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include María Molina‐Molina, Nazia Chaudhuri, C.T. Leonard, John Blaikley, Conal Hayton, Stefan Stanel, Soraya L. Vallés, Javier Alcácer, María Benlloch and Patricia Marchio. Their work appears in journals such as PLoS ONE, European Respiratory Journal and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.